Comparison

ASCO Guidelines vs HemeOncBuddy

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

ASCO Guidelines

Access comprehensive cancer care guidelines and interactive tools to inform treatment decisions. This app supports healthcare providers, patients, and caregivers in implementing recommended cancer care options for various cancer types, aiming to improve the quality of care.

Highlights
  • Guideline recommendations for cancer care
  • Interactive treatment decision tools
  • Supports healthcare providers
  • Informs patients and caregivers
  • Covers various cancer types
  • Regularly updated content
Features
Read full description

The ASCO Guidelines app is your go-to tool for implementing guideline recommendations into practice. This user-friendly app provides health care providers, patients, and caregivers with the recommended cancer care options for a variety of cancer types. It also includes interactive tools to inform treatment decisions at the point of care, thus increasing the quality of care provided to patients. The ASCO app is free to members and nonmembers, kept up to date, and will continue to grow as more guidelines and tools are added.

About

HemeOncBuddy

This app provides quick access to practice-changing clinical trials in Hematology and Oncology. It offers simplified summaries of trial background, inclusion/exclusion criteria, primary endpoints, and outcomes for easy reference.

Highlights
  • Practice-changing clinical trial summaries
  • Hematology and Oncology focus
  • Simplified trial information
  • Inclusion and exclusion criteria
  • Primary endpoints and outcomes
  • Quick reference tool
Features
Read full description

HemeOncBuddy is a free study hub built for hematology and oncology fellows and trainees - everything you need to keep up with the literature and prep for boards, in one fast, searchable app. WHAT'S INSIDE - 1,500+ pivotal clinical-trial summaries, each in the same structure (background, inclusion criteria, arms, primary/secondary endpoints, median follow-up, key results, notable toxicities) so you can scan them quickly. - A Question Bank with board-style questions, tutor and timed modes, explanations, and progress tracking. - ~2,000 active-recall flashcards across oncology, malignant and benign heme, and pharmacology — plus visual staging decks. - 120+ concise disease-site board-prep notes. - A conference & abstract-deadline tracker so you never miss a submission window. MADE FOR STUDYING - Full dark mode and adjustable text size. - Optional free account (Sign in with Apple, Google, or email) to sync your saved trials, Qbank progress, and notes across iPhone, iPad, and Mac. - No ads. No paywall. No login required to browse. HemeOncBuddy is an educational study aid only. It is not a substitute for medical advice, clinical judgment, or current guidelines, and must not be used to diagnose or treat patients. Always verify against primary literature and current guidelines.

Screenshots

ASCO Guidelines4 screens
HemeOncBuddy4 screens

Verdict

The call

The clearest difference is review sentiment: HemeOncBuddy at 100% against ASCO Guidelines's 57%. HemeOncBuddy also leads on rating (5.0 vs 4.8). ASCO Guidelines's advantage is update cadence (every 5 months vs every 24 months) and ratings volume (259 vs 18). On price, ads, in-app purchases and monetization model there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

HemeOncBuddy holds the better App Store score, 5.0 against 4.8. That said, the two scores are not equally well evidenced: ASCO Guidelines has 259 ratings behind it against 18, so its average is the more settled of the two. Written reviews point the same way: 57% of ASCO Guidelines's written reviews are positive against 100% of HemeOncBuddy's.

UpkeepUpdate frequency

ASCO Guidelines ships an update every 5 months, HemeOncBuddy every 24 months. Both last shipped on October 24, 2026.

Scorecard5 real differences · 5 level
ASCO Guidelines versus HemeOncBuddy: the parameters behind the verdict, then further details
ParameterASCO GuidelinesHemeOncBuddy
PriceFreeFree
Rating4.8 (259 ratings)5.0 (18 ratings) — better
Positive reviews57.1% of reviews100.0% of reviews — better
Number of ratings259 — better18
Update frequencyEvery 5 months — betterEvery 24 months
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS10.0 — better15.0
Further details — not scored
Size411 MB16 MB
Age rating12+17+
DeveloperAmerican Society of Clinical OncologyVeli Bakalov

Customer experience

ASCO Guidelines

All ratings257 ratings
Positive95.3%
Neutral1.6%
Negative3.1%
Written reviews7 reviews
Positive57.1%
Neutral0.0%
Negative42.9%

HemeOncBuddy

All ratings17 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews2 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

ASCO Guidelines

No in-app purchases

None

HemeOncBuddy

No in-app purchases

Questions

Is ASCO Guidelines free?
ASCO Guidelines is free to download, with no in-app purchases.
Is HemeOncBuddy free?
HemeOncBuddy is free to download, with no in-app purchases.
Which has better reviews, ASCO Guidelines or HemeOncBuddy?
HemeOncBuddy is rated higher. ASCO Guidelines averages 4.8 out of 5 from 259 ratings, while HemeOncBuddy averages 5.0 from 18 ratings.
Do ASCO Guidelines or HemeOncBuddy have ads?
Neither ASCO Guidelines nor HemeOncBuddy shows ads.
Which is updated more often, ASCO Guidelines or HemeOncBuddy?
ASCO Guidelines ships an update every 5 months, and HemeOncBuddy every 24 months. Most recently, ASCO Guidelines was updated on October 24, 2026 and HemeOncBuddy on October 24, 2026.

Other comparisons